The Children's Place Reports First Quarter 2024 Results
June 12, 2024 17:01 ET
|
The Children's Place, Inc.
SECAUCUS, N.J., June 12, 2024 (GLOBE NEWSWIRE) -- The Children’s Place, Inc. (Nasdaq: PLCE), an omni-channel children’s specialty portfolio of brands with an industry-leading digital-first model,...
NVIDIA Stockholder Meeting Set for June 26; Individuals Can Participate Online
June 12, 2024 17:00 ET
|
NVIDIA
SANTA CLARA, Calif., June 12, 2024 (GLOBE NEWSWIRE) -- NVIDIA today announced it will hold its 2024 Annual Meeting of Stockholders online on Thursday, June 26, at 9 a.m. PT. The meeting will take...
Lack of Career Progression, Upskilling and Flexibility in the Workplace Putting Australian Businesses Behind the Rest of the World, New Report Shows
June 12, 2024 17:00 ET
|
Kelly Services, Inc.
A lack of career progression, upskilling opportunities and flexible work options are making it difficult for Australian businesses to retain staff.
Dentsply Sirona Provides Update on June Investor Conference Participation
June 12, 2024 16:55 ET
|
DENTSPLY SIRONA Inc.
CHARLOTTE, N.C., June 12, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that it is canceling its participation in the Goldman...
Centurion Acquisition Corp. Announces Closing of $287.5 Million Initial Public Offering Including Full Exercise of Underwriters’ Over-Allotment Option
June 12, 2024 16:30 ET
|
Centurion Acquisition Corp.
NEW YORK, June 12, 2024 (GLOBE NEWSWIRE) -- Centurion Acquisition Corp. (Nasdaq: ALF) (the “Company”) today announced the closing of its initial public offering of 28,750,000 units, which includes...
Cellectis dévoile une approche de thérapie génique non-virale pour traiter la drépanocytose dans Nature Communications
June 12, 2024 16:30 ET
|
Cellectis Inc.
NEW YORK, 12 juin 2024 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS - Nasdaq: CLLS), société de biotechnologie de stade clinique, qui utilise sa technologie pionnière d'édition de génome...
Cellectis Unveils a Non-Viral Gene Therapy Approach for Sickle Cell Disease in Nature Communications
June 12, 2024 16:30 ET
|
Cellectis Inc.
NEW YORK, June 12, 2024 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to...
NANOBIOTIX ORGANISE UNE DISCUSSION VIRTUELLE ENTRE EXPERTS SUR LE POTENTIEL DE NBTXR3 EN IMMUNOTHÉRAPIE DANS LE CANCER DE LA TÊTE ET DU COU ET D’AUTRES INDICATIONS LE 18 JUIN 2024
June 12, 2024 16:15 ET
|
Nanobiotix S.A.
PARIS et CAMBRIDGE, Mass., 12 juin 2024 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext : NANO –– NASDAQ : NBTX – la « Société »), société française de biotechnologie en phase de développement clinique...
NANOBIOTIX to Host Virtual KOL Event Discussing Potential of NBTXR3 Combined With Immunotherapy in Head and Neck Cancer and Beyond on June 18, 2024
June 12, 2024 16:15 ET
|
Nanobiotix S.A.
PARIS and CAMBRIDGE, Mass., June 12, 2024 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the ‘‘Company’’), a late-clinical stage biotechnology company pioneering physics-based...
Connect Biopharma Announces New Leadership and Chair of the Board of Directors
June 12, 2024 16:15 ET
|
Connect Biopharma Holdings Limited
Industry leader Barry Quart, Pharm.D. appointed as Chief Executive Officer succeeding Zheng Wei, Ph.D., who will remain on the Board of Directors and serve as an advisor to assist with the...